Improving treatment of chromoblastomycosis: the potential of COP1T-HA and antimicrobial photodynamic therapy against Fonsecaea monophora in vitro.

Abstract

Fonsecaea monophora is one of the common pathogenic species of Chromoblastomycosis (CBM). Antimicrobial photodynamic therapy (aPDT) shows promise as a new treatment for CBM. In this study, we evaluated the effectiveness of COP1T-HA which is a porous organic cage and aPDT against Fonsecaea spp. in vitro.